Literature DB >> 26741515

Procalcitonin Levels in Acute Respiratory Infection.

Kelsey M Henriquez1, Mary S Hayney1, David P Rakel2, Bruce Barrett2.   

Abstract

Procalcitonin (PCT) is a biomarker of inflammation that is used to help make clinical decisions, like starting antibiotics or admitting a patient to the hospital. While PCT levels have been widely studied in pneumonia, levels in less severe acute respiratory infections (ARI) have not been well studied. To measure PCT levels in otherwise healthy adults during ARI, we followed 99 healthy adults during the cold and flu season, collecting blood specimens for PCT testing at baseline, and when participants presented with ARI. Ninety-six percent of the ARI samples had PCT levels <0.05 ng/mL. The remaining 4% were <0.25 ng/mL. These data suggest that PCT is not a useful test in ARI of mild-to-moderate severity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26741515      PMCID: PMC4782030          DOI: 10.1089/vim.2015.0106

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  15 in total

1.  Acute respiratory diseases of viral etiology. VII. Present concepts of the common cold.

Authors:  G G JACKSON; H F DOWLING; R L MULDOON
Journal:  Am J Public Health Nations Health       Date:  1962-06

2.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

3.  Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Ann Ward; Chidi N Obasi; Roger Brown; Zhengjun Zhang; Aleksandra Zgierska; James Gern; Rebecca West; Tola Ewers; Shari Barlow; Michele Gassman; Christopher L Coe
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

Review 4.  Procalcitonin for the clinical laboratory: a review.

Authors:  Hans-Gerhard Schneider; Que Thanh Lam
Journal:  Pathology       Date:  2007-08       Impact factor: 5.306

Review 5.  Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.

Authors:  M Christ-Crain; B Müller
Journal:  Eur Respir J       Date:  2007-09       Impact factor: 16.671

6.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Authors:  Lila Bouadma; Charles-Edouard Luyt; Florence Tubach; Christophe Cracco; Antonio Alvarez; Carole Schwebel; Frédérique Schortgen; Sigismond Lasocki; Benoît Veber; Monique Dehoux; Maguy Bernard; Blandine Pasquet; Bernard Régnier; Christian Brun-Buisson; Jean Chastre; Michel Wolff
Journal:  Lancet       Date:  2010-01-25       Impact factor: 79.321

Review 7.  Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

8.  Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Marcel Wolbers; Isabelle Widmer; Stefanie Neidert; Thomas Fricker; Claudine Blum; Ursula Schild; Katharina Regez; Ronald Schoenenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Mueller
Journal:  JAMA       Date:  2009-09-09       Impact factor: 56.272

9.  High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses.

Authors:  Wai-Ming Lee; Kris Grindle; Tressa Pappas; David J Marshall; Michael J Moser; Edward L Beaty; Peter A Shult; James R Prudent; James E Gern
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

10.  The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid.

Authors:  Bruce Barrett; Roger Brown; Marlon Mundt; Nasia Safdar; Leota Dye; Rob Maberry; Jennifer Alt
Journal:  J Clin Epidemiol       Date:  2005-06       Impact factor: 6.437

View more
  4 in total

1.  Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.

Authors:  Susanna Esposito; Sonia Bianchini; Monia Gambino; Barbara Madini; Giada Di Pietro; Giulia Umbrello; Maria Lory Presicce; Luca Ruggiero; Leonardo Terranova; Nicola Principi
Journal:  BMC Pulm Med       Date:  2016-07-20       Impact factor: 3.317

2.  Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults.

Authors:  Mary S Hayney; Kelsey M Henriquez; Jodi H Barnet; Tola Ewers; Heather M Champion; Sean Flannery; Bruce Barrett
Journal:  J Clin Virol       Date:  2017-03-16       Impact factor: 3.168

3.  Multicenter Evaluation of the BioFire FilmArray Pneumonia/Pneumonia Plus Panel for Detection and Quantification of Agents of Lower Respiratory Tract Infection.

Authors:  Caitlin N Murphy; Randal Fowler; Joan Miquel Balada-Llasat; Amanda Carroll; Hanna Stone; Oluseun Akerele; Blake Buchan; Sam Windham; Amanda Hopp; Shira Ronen; Ryan F Relich; Rebecca Buckner; Del A Warren; Romney Humphries; Shelly Campeau; Holly Huse; Suki Chandrasekaran; Amy Leber; Kathy Everhart; Amanda Harrington; Christina Kwong; Andrew Bonwit; Jennifer Dien Bard; Samia Naccache; Cynthia Zimmerman; Barbara Jones; Cory Rindlisbacher; Maggie Buccambuso; Angela Clark; Margarita Rogatcheva; Corrin Graue; Kevin M Bourzac
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

4.  Meditation or exercise for preventing acute respiratory infection (MEPARI-2): A randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Roger Brown; Aleksandra E Zgierska; Shari Barlow; Supriya Hayer; Jodi H Barnet; Elisa R Torres; Christopher L Coe
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.